AGN: Allergan plc - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Allergan plc

NYSE:AGN

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$193.02
Loss Chance
46.3%
4.44JITTA SCORE
8.42%Under Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Bausch Health Companies
NYSE:BHC
5.05
$5.42
80.16%
Corcept Therapeutics
NASDAQ:CORT
4.53
$56.37
385.31%
Endo International plc
NASDAQ:ENDP
2.69
$0.00
94.10%
Innoviva
NASDAQ:INVA
5.41
$21.97
23.59%
Johnson & Johnson
NYSE:JNJ
6.93
$226.71
164.36%
Jitta Factors
Growth Opportunity (30)
Recent Business Performance (38)
Financial Strength (58)
Return to Shareholders (32)
Competitive Advantage (51)
Jitta Signs
Share RepurchaseEvery Year
Revenue and EarningEarning loss detected in 2015
Operating MarginInconsistent
Recent Business PerformanceEarning decline 89.69% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.44
8.42%
3.05
95.69%
3.06
202.58%
Pharmaceuticals
5.05
80.16%
4.53
385.31%
2.69
94.10%
COMPANY DESCRIPTION
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, central nervous system, women’s health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; In addition, it develops medical and cosmetic treatments; treatments for neurodegenerative disorders; and inflammatory and fibrotic diseases. It has a collaboration, option, and license agreement with Lyndra, Inc. to develop orally administered products for the treatment of Alzheimer’s disease; strategic alliance and option agreement with Editas Medicine, Inc.; and Allergan plc also has licensing agreements with Assembly Biosciences, Inc. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was incorporated in 2013 and is headquartered in Dublin, Ireland. As of May 8, 2020, Allergan plc operates as a subsidiary of AbbVie Inc.
www.allergan.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.